Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rydén L[au]:

Search results

Items: 1 to 50 of 659

1.

Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable.

Cosentino F, Ceriello A, Baeres FMM, Fioretto P, Garber A, Stough WG, George JT, Grant PJ, Khunti K, Langkilde AM, Plutzky J, Rydén L, Scheen A, Standl E, Tuomilehto J, Zannad F.

Eur Heart J. 2018 Nov 16. doi: 10.1093/eurheartj/ehy677. [Epub ahead of print] No abstract available.

PMID:
30445605
2.

The Gothenburg H70 Birth cohort study 2014-16: design, methods and study population.

Rydberg Sterner T, Ahlner F, Blennow K, Dahlin-Ivanoff S, Falk H, Havstam Johansson L, Hoff M, Holm M, Hörder H, Jacobsson T, Johansson B, Johansson L, Kern J, Kern S, Machado A, Mellqvist Fässberg M, Nilsson J, Ribbe M, Rothenberg E, Rydén L, Sadeghi A, Sacuiu S, Samuelsson J, Sigström R, Skoog J, Thorvaldsson V, Waern M, Westman E, Wetterberg H, Zetterberg H, Zetterberg M, Zettergren A, Östling S, Skoog I.

Eur J Epidemiol. 2018 Nov 13. doi: 10.1007/s10654-018-0459-8. [Epub ahead of print]

PMID:
30421322
3.

Antiphospholipid Antibodies in Patients With Myocardial Infarction.

Grosso G, Sippl N, Kjellström B, Amara K, de Faire U, Elvin K, Lindahl B, Näsman P, Rydén L, Norhammar A, Svenungsson E.

Ann Intern Med. 2018 Oct 23. doi: 10.7326/M18-2130. [Epub ahead of print] No abstract available.

PMID:
30357274
4.

Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.

De Bacquer D, De Smedt D, Kotseva K, Jennings C, Wood D, Rydén L, Gyberg V, Shahim B, Amouyel P, Bruthans J, Castro Conde A, Cífková R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D, Wagner M, De Backer G; EUROASPIRE Investigators.

Eur J Epidemiol. 2018 Oct 23. doi: 10.1007/s10654-018-0454-0. [Epub ahead of print]

PMID:
30353266
5.

Heart failure and the risk of acute kidney injury in relation to ejection fraction in patients undergoing coronary artery bypass grafting.

Hertzberg D, Sartipy U, Lund LH, Rydén L, Pickering JW, Holzmann MJ.

Int J Cardiol. 2018 Sep 28. pii: S0167-5273(18)34815-0. doi: 10.1016/j.ijcard.2018.09.092. [Epub ahead of print]

PMID:
30297189
6.

Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje.

Shahim B, Hasselberg S, Boldt-Christmas O, Gyberg V, Mellbin L, Rydén L.

Eur J Prev Cardiol. 2018 Oct 5:2047487318805582. doi: 10.1177/2047487318805582. [Epub ahead of print]

PMID:
30289273
7.

Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data.

Ferrannini G, Rydén L.

Clin Sci (Lond). 2018 Sep 18;132(18):2003-2012. doi: 10.1042/CS20171374. Print 2018 Sep 28. Review.

PMID:
30232238
8.

Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function.

Johansson I, Dahlström U, Edner M, Näsman P, Rydén L, Norhammar A.

Diab Vasc Dis Res. 2018 Nov;15(6):494-503. doi: 10.1177/1479164118794619. Epub 2018 Sep 3.

PMID:
30176743
9.

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.

De Smedt D, Annemans L, De Backer G, Kotseva K, Rydèn L, Wood D, Amouyel P, Bruthans J, Cifkova R, De Sutter J, Dolzhenko M, Erglis A, Gotcheva N, Gyberg V, Laucevicius A, Lovic D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Stagmo M, De Bacquer D.

Int J Cardiol. 2018 Dec 1;272:20-25. doi: 10.1016/j.ijcard.2018.06.104. Epub 2018 Jun 28.

PMID:
30172478
10.

Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time.

Ehinger A, Bendahl PO, Rydén L, Fernö M, Alkner S.

APMIS. 2018 Sep;126(9):746-754. doi: 10.1111/apm.12884.

PMID:
30160021
11.

A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: study protocol of the SCAN-B resilience study.

Axelsson U, Rydén L, Johnsson P, Edén P, Månsson J, Hallberg IR, Borrebaeck CAK.

BMC Cancer. 2018 Aug 6;18(1):789. doi: 10.1186/s12885-018-4669-y.

12.

The Accuracy of Point-of-Care Equipment for Glucose Measurement in Screening for Dysglycemia in Patients with Coronary Artery Disease.

Shahim B, Kjellström B, Gyberg V, Jennings C, Smetana S, Rydén L.

Diabetes Technol Ther. 2018 Sep;20(9):596-602. doi: 10.1089/dia.2018.0157. Epub 2018 Aug 3.

PMID:
30074818
13.

Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.

Sharma M, Hart RG, Smith EE, Bosch J, Yuan F, Casanova A, Eikelboom JW, Connolly SJ, Wong G, Diaz R, Lopez-Jaramillo P, Ertl G, Störk S, Dagenais GR, Lonn EM, Ryden L, Tonkin AM, Varigos JD, Bhatt DL, Branch KR, Probstfield JL, Kim JH, Ha JW, O'Donnell M, Vinereanu D, Fox KA, Liang Y, Liu L, Zhu J, Pogosova N, Maggioni AP, Avezum A, Piegas LS, Keltai K, Keltai M, Cook Bruns N, Berkowitz S, Yusuf S.

Int J Stroke. 2018 Jul 30:1747493018784478. doi: 10.1177/1747493018784478. [Epub ahead of print]

PMID:
30058959
14.

Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort.

Ritsinger V, Brismar K, Mellbin L, Näsman P, Rydén L, Söderberg S, Norhammar A.

Diab Vasc Dis Res. 2018 Sep;15(5):387-395. doi: 10.1177/1479164118781892. Epub 2018 Jul 11.

PMID:
29992830
15.

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.

Schrieks IC, Nozza A, Stähli BE, Buse JB, Henry RR, Malmberg K, Neal B, Nicholls SJ, Rydén L, Mellbin L, Svensson A, Wedel H, Weichert A, Lincoff AM, Tardif JC, Grobbee DE, Schwartz GG.

Diabetes Care. 2018 Aug;41(8):1792-1800. doi: 10.2337/dc18-0158. Epub 2018 Jun 14.

16.

On the prognostic value of post-load glucose in patients with coronary artery disease.

Rydén L, Shahim B, Standl E.

Eur Heart J. 2018 Aug 1;39(29):2746-2748. doi: 10.1093/eurheartj/ehy320. No abstract available.

PMID:
29893842
17.

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.

Larsson AM, Jansson S, Bendahl PO, Levin Tykjaer Jörgensen C, Loman N, Graffman C, Lundgren L, Aaltonen K, Rydén L.

Breast Cancer Res. 2018 Jun 8;20(1):48. doi: 10.1186/s13058-018-0976-0.

18.

Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.

Theodorakis MJ, Coleman RL, Feng H, Chan J, Chiasson JL, Ge J, Gerstein HC, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Tendera M, Tuomilehto J, Yang W, Hu D, Pan C, Holman RR; ACE Study Group.

Am Heart J. 2018 May;199:170-175. doi: 10.1016/j.ahj.2017.09.001. Epub 2017 Sep 8. No abstract available.

PMID:
29754657
19.

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary Syndrome.

Stähli BE, Nozza A, Schrieks IC, Buse JB, Malmberg K, Mellbin L, Neal B, Nicholls SJ, Rydén L, Svensson A, Wedel H, Weichert A, Lincoff AM, Grobbee DE, Tardif JC, Schwartz GG.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2522-2533. doi: 10.1210/jc.2017-02772.

PMID:
29659887
20.

Severe Periodontitis Is Associated with Myocardial Infarction in Females.

Nordendahl E, Gustafsson A, Norhammar A, Näsman P, Rydén L, Kjellström B; PAROKRANK Steering Committee.

J Dent Res. 2018 Sep;97(10):1114-1121. doi: 10.1177/0022034518765735. Epub 2018 Mar 29.

PMID:
29596754
21.
22.

Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.

Roswall P, Bocci M, Bartoschek M, Li H, Kristiansen G, Jansson S, Lehn S, Sjölund J, Reid S, Larsson C, Eriksson P, Anderberg C, Cortez E, Saal LH, Orsmark-Pietras C, Cordero E, Haller BK, Häkkinen J, Burvenich IJG, Lim E, Orimo A, Höglund M, Rydén L, Moch H, Scott AM, Eriksson U, Pietras K.

Nat Med. 2018 May;24(4):463-473. doi: 10.1038/nm.4494. Epub 2018 Mar 12.

23.

Genetic Variation in FOXO3 is Associated with Self-Rated Health in a Population-Based Sample of Older Individuals.

Zettergren A, Kern S, Rydén L, Östling S, Blennow K, Zetterberg H, Falk H, Skoog I.

J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1453-1458. doi: 10.1093/gerona/gly021.

24.

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence.

Jansson S, Aaltonen K, Bendahl PO, Falck AK, Karlsson M, Pietras K, Rydén L.

Breast Cancer Res Treat. 2018 Jun;169(2):231-241. doi: 10.1007/s10549-018-4664-7. Epub 2018 Jan 29.

25.
26.

Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.

Rydén L, Loman N, Larsson C, Hegardt C, Vallon-Christersson J, Malmberg M, Lindman H, Ehinger A, Saal LH, Borg Å.

Br J Surg. 2018 Jan;105(2):e158-e168. doi: 10.1002/bjs.10741.

27.

Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention).

Gerstein HC, Jung H, Rydén L, Diaz R, Gilbert RE, Yusuf S; ORIGIN Investigators.

Circulation. 2018 Jan 2;137(1):88-90. doi: 10.1161/CIRCULATIONAHA.117.030924. No abstract available.

PMID:
29279340
28.

Anaemia and iron deficiency in heart failure: epidemiological gaps, diagnostic challenges and therapeutic barriers in sub-Saharan Africa.

Makubi A, Lwakatare J, Ogah OS, Rydén L, Lund LH, Makani J.

Cardiovasc J Afr. 2017 Sep/Oct;28(5):331-337. doi: 10.5830/CVJA-2017-001. Review.

29.

Correction to: Updates on cardiovascular outcome trials in diabetes.

Schnell O, Rydén L, Standl E, Ceriello A; D&CVD EASD Study Group.

Cardiovasc Diabetol. 2017 Nov 15;16(1):150. doi: 10.1186/s12933-017-0633-4.

30.

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators.

Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10.

31.

Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes.

Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, Morocutti G, Ferri M, Cavallini C, Eijkemans MJ, Stähli BE, Schrieks IC, Toyama T, Lambers Heerspink HJ, Malmberg K, Schwartz GG, Lincoff AM, Ryden L, Tardif JC, Grobbee DE.

Diab Vasc Dis Res. 2018 Jan;15(1):14-23. doi: 10.1177/1479164117735493. Epub 2017 Oct 20.

PMID:
29052439
32.

Updates on cardiovascular outcome trials in diabetes.

Schnell O, Rydén L, Standl E, Ceriello A; D&CVD EASD Study Group.

Cardiovasc Diabetol. 2017 Oct 11;16(1):128. doi: 10.1186/s12933-017-0610-y. Review. Erratum in: Cardiovasc Diabetol. 2017 Nov 15;16(1):150.

33.

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.

Holman RR, Coleman RL, Chan JCN, Chiasson JL, Feng H, Ge J, Gerstein HC, Gray R, Huo Y, Lang Z, McMurray JJ, Rydén L, Schröder S, Sun Y, Theodorakis MJ, Tendera M, Tucker L, Tuomilehto J, Wei Y, Yang W, Wang D, Hu D, Pan C; ACE Study Group.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):877-886. doi: 10.1016/S2213-8587(17)30309-1. Epub 2017 Sep 13. Erratum in: Lancet Diabetes Endocrinol. 2017 Nov;5(11):e7.

PMID:
28917545
34.

Fungal coronary embolus while on extracorporeal membrane oxygenation.

Martinez FE, Ryden L, Leaver R, Mendoza J, Havill K.

Anaesth Intensive Care. 2017 Sep;45(5):634-635. No abstract available.

35.

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators.

N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.

36.

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.

Alkner S, Jensen MB, Rasmussen BB, Bendahl PO, Fernö M, Rydén L, Mouridsen H; Danish Breast Cancer Cooperative Group.

Breast Cancer Res Treat. 2017 Nov;166(2):481-490. doi: 10.1007/s10549-017-4416-0. Epub 2017 Aug 1.

37.

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial.

Bosch J, Eikelboom JW, Connolly SJ, Bruns NC, Lanius V, Yuan F, Misselwitz F, Chen E, Diaz R, Alings M, Lonn EM, Widimsky P, Hori M, Avezum A, Piegas LS, Bhatt DL, Branch KRH, Probstfield JL, Liang Y, Liu L, Zhu J, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Fox KAA, Kakkar A, Parkhomenko AN, Ertl G, Störk S, Keltai K, Keltai M, Ryden L, Dagenais GR, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Ha JW, Tonkin AM, Varigos JD, Lewis BS, Felix C, Yusoff K, Steg PG, Aboyans V, Metsarinne KP, Anand SS, Hart RG, Lamy A, Moayyedi P, Leong DP, Sharma M, Yusuf S.

Can J Cardiol. 2017 Aug;33(8):1027-1035. doi: 10.1016/j.cjca.2017.06.001. Epub 2017 Jun 8. Review.

38.

Nomograms for preoperative prediction of axillary nodal status in breast cancer.

Dihge L, Bendahl PO, Rydén L.

Br J Surg. 2017 Oct;104(11):1494-1505. doi: 10.1002/bjs.10583. Epub 2017 Jul 18.

39.

Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.

Abrahamsson J, Aaltonen K, Engilbertsson H, Liedberg F, Patschan O, Rydén L, Sjödahl G, Gudjonsson S.

Urol Oncol. 2017 Oct;35(10):606.e9-606.e16. doi: 10.1016/j.urolonc.2017.05.021. Epub 2017 Jul 1.

PMID:
28676151
40.

Tumor tissue protein signatures reflect histological grade of breast cancer.

Skoog P, Ohlsson M, Fernö M, Rydén L, Borrebaeck CAK, Wingren C.

PLoS One. 2017 Jun 26;12(6):e0179775. doi: 10.1371/journal.pone.0179775. eCollection 2017.

41.

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology.

Shahim B, De Bacquer D, De Backer G, Gyberg V, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L.

Diabetes Care. 2017 Sep;40(9):1233-1240. doi: 10.2337/dc17-0245. Epub 2017 Jun 21.

42.

Acute kidney injury-an overview of diagnostic methods and clinical management.

Hertzberg D, Rydén L, Pickering JW, Sartipy U, Holzmann MJ.

Clin Kidney J. 2017 Jun;10(3):323-331. doi: 10.1093/ckj/sfx003. Epub 2017 Mar 15.

43.

Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riddle MC, Rydén L, Xavier D, Atisso CM, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona-Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw J, Sheu WH, Temelkova-Kurktschiev T; REWIND Trial Investigators.

Diabetes Obes Metab. 2018 Jan;20(1):42-49. doi: 10.1111/dom.13028. Epub 2017 Jul 14.

PMID:
28573765
44.

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Rydén L, Olofsson Bagge R, Sund M, Johansson H, Lundstedt D; SENOMAC Trialists’ Group.

BMC Cancer. 2017 May 26;17(1):379. doi: 10.1186/s12885-017-3361-y.

45.

New Hope For People With Dysglycemia and Cardiovascular Disease Manifestations: Reduction of Acute Coronary Events With Pioglitazone.

Rydén L, Mellbin L.

Circulation. 2017 May 16;135(20):1894-1896. doi: 10.1161/CIRCULATIONAHA.117.027952. No abstract available.

PMID:
28507248
46.

Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology.

Wagner M, Wanner C, Kotseva K, Wood D, De Bacquer D, Rydén L, Störk S, Heuschmann PU; EUROASPIRE IV investigators.

Eur J Prev Cardiol. 2017 Jul;24(11):1168-1180. doi: 10.1177/2047487317708891. Epub 2017 May 15.

47.

Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.

Aaltonen KE, Novosadová V, Bendahl PO, Graffman C, Larsson AM, Rydén L.

Oncotarget. 2017 Jul 11;8(28):45544-45565. doi: 10.18632/oncotarget.17271.

48.

Saliva and plasma levels of cardiac-related biomarkers in post-myocardial infarction patients.

Rathnayake N, Buhlin K, Kjellström B, Klinge B, Löwbeer C, Norhammar A, Rydén L, Sorsa T, Tervahartiala T, Gustafsson A; PAROKRANK Steering Committee.

J Clin Periodontol. 2017 Jul;44(7):692-699. doi: 10.1111/jcpe.12740. Epub 2017 Jun 20.

PMID:
28453865
49.

Corrections needed to 2016 ESC and AHA guidelines on heart failure.

Rydén L, Van de Werf F, Armstrong PW, McGuire DK, Standl E, Peterson ED, Holman RR.

Lancet Diabetes Endocrinol. 2017 May;5(5):325-326. doi: 10.1016/S2213-8587(17)30102-X. Epub 2017 Apr 5. No abstract available. Erratum in: Lancet Diabetes Endocrinol. 2017 Jun;5(6):e4.

PMID:
28395875
50.

The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial.

van Steen SC, Schrieks IC, Hoekstra JB, Lincoff AM, Tardif JC, Mellbin LG, Rydén L, Grobbee DE, DeVries JH; AleCardio study group.

Eur J Prev Cardiol. 2017 May;24(8):858-866. doi: 10.1177/2047487317692664. Epub 2017 Feb 10.

PMID:
28186441

Supplemental Content

Support Center